Current Status of Oral Disease-Modifying Treatment Effects on Cognitive Outcomes in Multiple Sclerosis: A Scoping Review

Current Status of Oral Disease-Modifying Treatment Effects on Cognitive Outcomes in Multiple Sclerosis: A Scoping Review

Introduction. Cognitive impairment represents one of the most hidden and disabling clinical aspects of multiple sclerosis (MS). In this regard, the major challenges are represented by the need for a comprehensive and standardised cognitive evaluation of each patient, both at disease onset and during...

Full description

Bibliographic Details
Main Authors: Vincenzo Carlomagno, Massimiliano Mirabella, Matteo Lucchini
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Bioengineering
Subjects:
multiple sclerosis
cognitive impairment
fingolimod
siponimod
ozanimod
cladribine
Online Access:https://www.mdpi.com/2306-5354/10/7/848

Similar Items

Similar Items